Correction: Combined poly-ADP ribose polymerase and ataxia-telangiectasia mutated/Rad3-related inhibition targets ataxia-telangiectasia mutated-deficient lung cancer cells.

Br J Cancer

Departments of Biochemistry and Molecular Biology, Robson DNA Science Centre and Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, Alberta, T2N 1N4, Canada.

Published: June 2020

This Article was originally published under Nature Research's License to Publish, but has now been made available under a CC BY 4.0 license. This has now been corrected in both the PDF and HTML versions of the Article.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283263PMC
http://dx.doi.org/10.1038/s41416-020-0841-7DOI Listing

Publication Analysis

Top Keywords

correction combined
4
combined poly-adp
4
poly-adp ribose
4
ribose polymerase
4
polymerase ataxia-telangiectasia
4
ataxia-telangiectasia mutated/rad3-related
4
mutated/rad3-related inhibition
4
inhibition targets
4
targets ataxia-telangiectasia
4
ataxia-telangiectasia mutated-deficient
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!